Consun Pharmaceutical Group (1681.HK) Earnings Analysis
Consun Pharmaceutical Group (1681.HK) next reports earnings on 2026-08-25. Trailing P/E 9.15.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 1681.HK next report earnings?
| Next earnings date | 2026-08-25 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 2.06B |
1681.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-08-19 | 0.636 HKD | n/a | n/a | n/a |
| 2024-08-21 | 0.529 HKD | n/a | n/a | n/a |
1681.HK valuation and analyst view
| Trailing P/E | 9.15 |
|---|---|
| Trailing EPS | 1.265 HKD |
| Price / book | 2.18 |
| Dividend yield | 5.42% |
| Market cap | 11.24B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Consun Pharmaceutical Group (1681.HK)'s next earnings date?
Consun Pharmaceutical Group is next scheduled to report on 2026-08-25 and revenue estimate of 2.06B.
Did 1681.HK beat earnings last quarter?
Consensus estimate data was not available for 1681.HK's 2025-08-19 report.
What is 1681.HK's current P/E ratio and EPS?
1681.HK trades at a trailing P/E of 9.15 on trailing EPS of 1.2647978412645795 HKD.
What do analysts rate 1681.HK?
1681.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.